Medicare Enrolled

Dr. Sandeep Gupta, M.D.

Rheumatology · Bronx, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3594 E TREMONT AVE, Bronx, NY 10465
7185975800
In practice since 2006 (20 years)
NPI: 1194794305 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gupta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gupta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gupta

Dr. Sandeep Gupta is a rheumatology specialist in Bronx, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gupta performed 19,335 Medicare services across 1,624 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gupta received a total of $21,759 from 39 pharmaceutical and/or device companies across 1022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gupta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 14% volume in NY $21,759 industry payments

Medicare Practice Summary

Medicare Utilization ↗
19,335
Medicare services
Top 14% in NY for rheumatology
1,624
Unique beneficiaries
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~967 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 12,960 $18 $54
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,290 $26 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
819 $80 $327
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
804 $1 $11
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
751 $110 $350
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
361 $13 $60
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
193 $93 $250
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
142 $27 $125
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
133 $1 $15
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
132 $150 $430
5% dextrose/water (500 ml = 1 unit) 121 $1 $15
Orthovisc intra-articular injection
An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning.
103 $101 $400
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
96 $129 $369
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
85 $53 $257
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
84 $36 $40
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
73 $71 $80
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
67 $60 $200
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
60 $61 $182
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
36 $49 $200
Influenza vaccine, quadrivalent, 0.5 ml dosage 13 $20 $50
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
12 $52 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.3% high complexity
75.9% medium
10.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,759
Total received (2018-2024)
Avg $3,108/year across 7 years
Top 19% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
1,022
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,711 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,048 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,707
2023
$3,342
2022
$4,016
2021
$2,934
2020
$2,273
2019
$2,492
2018
$3,996

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$482
ABBVIE INC.
$396
GlaxoSmithKline, LLC.
$316
PFIZER INC.
$301
Lilly USA, LLC
$273
AstraZeneca Pharmaceuticals LP
$220
Mallinckrodt Hospital Products Inc.
$213
Janssen Biotech, Inc.
$180
Novartis Pharmaceuticals Corporation
$104
UCB, Inc.
$57
E.R. Squibb & Sons, L.L.C.
$48
SCILEX PHARMACEUTICALS INC.
$42
Bioventus LLC
$27
GENZYME CORPORATION
$24
ANI Pharmaceuticals, Inc.
$23
Top 3 companies account for 44.1% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,676
ABBVIE INC.
$2,051
PFIZER INC.
$1,723
Lilly USA, LLC
$1,663
GlaxoSmithKline, LLC.
$1,415
Janssen Biotech, Inc.
$1,152
UCB, Inc.
$1,021
Mallinckrodt Hospital Products Inc.
$875
Horizon Therapeutics plc
$871
E.R. Squibb & Sons, L.L.C.
$857
Novartis Pharmaceuticals Corporation
$794
GE Healthcare
$765
Regeneron Healthcare Solutions, Inc.
$750
AstraZeneca Pharmaceuticals LP
$716
AbbVie Inc.
$683
AbbVie, Inc.
$635
Boehringer Ingelheim Pharmaceuticals, Inc.
$625
Hikma Pharmaceuticals USA
$373
Mallinckrodt Enterprises LLC
$371
Mallinckrodt LLC
$332
Flexion Therapeutics, Inc.
$277
Aurinia Pharma U.S., Inc.
$228
Genentech USA, Inc.
$160
Radius Health, Inc.
$119
Bioventus LLC
$96
GENZYME CORPORATION
$92
DePuy Synthes Sales Inc.
$81
Celgene Corporation
$60
Sobi, Inc
$43
SCILEX PHARMACEUTICALS INC.
$42
Alexion Pharmaceuticals, Inc.
$39
Ironwood Pharmaceuticals, Inc
$36
West-Ward Pharmaceuticals
$33
ANI Pharmaceuticals, Inc.
$23
Eyevance Pharmaceuticals LLC
$21
Avanir Pharmaceuticals, Inc.
$19
Organon LLC
$16
Horizon Pharma plc
$15
MEDAC PHARMA, INC.
$13
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUZALLO · Durolane · EVENITY · Enbrel · FORTEO · GELSYN 3 · HADLIMA · HUMIRA · Humira · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · NUEDEXTA · OFEV · ORENCIA · ORTHOVISC · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SUPARTZ FX SODIUM HYALURONATE · Supartz Fx Sodium Hyaluronate · TALTZ · TAVNEOS · TREMFYA · Tobradex ST · Tymlos · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Bronx?
Compare rheumatologists in the Bronx area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
384
Per 100K population
27.1
County median income
$49,036
Nearest hospital
JACOBI MEDICAL CENTER
1.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gupta is a mixed practice specialist, with above-average Medicare volume (top 14% in NY), with low-engagement industry engagement in the top 19% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gupta experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Gupta performed 12,960 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gupta receive payments from pharmaceutical companies?
Yes. Dr. Gupta received a total of $21,759 from 39 companies across 1,022 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gupta's costs compare to other rheumatologists in Bronx?
Dr. Gupta's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gupta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →